|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1631168
|
|
Name of medicinal product:
|
Amoxibactin vet
|
|
Active substances:
|
|
|
ATC code:
|
QJ01CA04
|
|
Dosage form:
|
tablet
|
|
Route of administration:
|
oral use
|
|
Strengh:
|
50mg
|
|
Amount in package:
|
500TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Treatment of primary and secondary infections of the airways, such as rhinitis caused by Pasteurella spp. and Streptococcus spp., and bronchopneumonia caused by Pasteurella spp., Escherichia coli and Gram-positive cocci.
Treatment of primary infections of the urogenital tract, such as pyelonephritis and infections of the lower urinary tract caused by Escherichia coli, Proteus spp. and Gram-positive cocci, endometritis caused by Escherichia coli, Streptococcus canis and Proteus spp., and vaginitis as a result of mixed infections.
Treatment of mastitis caused by Gram-positive cocci and Escherichia coli.
Treatment of local skin infections caused by Streptococcus spp.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated May 29, 2020)
|
|
Package information leaflet (PIL):
|
EST (last updated May 29, 2020)
|
|
Labelling:
|
(last updated May 29, 2020)
|
|
Withdrawal time:
|
Ei rakendata.
|
|
Species:
|
kass, koer
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
Le Vet. Beheer B.V.
|
|
Marketing authorization number:
|
1880
|
|
Marketing authorization issued on:
|
November 14, 2014
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Decentralised
|
Entry/Changing date:
May 27, 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere